Screening for viral and protozoal infections in pregnancy. A review

P. Klapper,D. Morris
DOI: https://doi.org/10.1111/j.1471-0528.1990.tb02467.x
1990-11-01
British Journal of Obstetrics and Gynaecology
Abstract:As a result of widespread publicity in the lay press and on radio and television, antenatal clinics in thc UK have recently becn inundated with demands from healthy pregnant women that current serological screening for rubella, hepatitis B, and human immunodeficiency viruses in pregnancy be expanded to encompass two additional agents: cytomegalovirus (CMV) and thc protozoan Toxoplusma gondii. Some clinicians have suggested that screening for a third infective agent, parvovirus B19, should also be included. The value of T. goizdii and CMV screening has been both passionately supported and vigorously refuted in the medical press of this country (Joynson & Payne 1988; Ho-Yen et ul. 1988; Salmon 1988; Editorial 1989a) and of the United States (McCabe & Remirigton 1988~; Thorpc ef ul. 1988; Yow 1989). To rcach a dispassionate conclusion regarding the need to expand serological screcning. wc havc rcviewcd the currently available laboratory and clinical data.
What problem does this paper attempt to address?